LPL and metabolic syndrome: Firstly, GALT2 directly regulates HDL metabolism of mammalian (209); secondly, GALT2 act as an inhibitor of ANGPTL3, which causes dyslipidemia (210); thirdly, LPL activity is controlled by ANGPTL3, and LPL is a key enzyme in lipid metabolism (211).